Target intelligence / Profile preview

Bacterial cell enzyme

Molecular classification
Enzyme, Hydrolase, Oxidoreductase, Transferase, Lyase, Ligase, Isomerase, (sometimes) Translocase
01

Overview

"Bacterial cell enzyme" is not a single molecular entity but a generic term referring to any enzyme produced by a bacterial cell. These enzymes catalyze diverse chemical reactions central to bacterial metabolism (e.g., glycolysis, cell wall biosynthesis), genetic information processing (e.g., DNA replication enzymes), and virulence (e.g., secreted toxins). Bacterial enzymes are key targets for antimicrobial drugs, as inhibiting essential bacterial enzymes can selectively kill or stall bacterial growth. Common antibacterial targets include the enzymes involved in cell wall synthesis (penicillin-binding proteins, β-lactamases), DNA replication, RNA transcription, and protein synthesis. The term itself is non-specific and should be replaced with a precise enzyme name (e.g., "β-lactamase," "DNA gyrase") in scientific contexts, as "various bacterial cell enzymes" is too broad to directly map to a single canonical target or therapeutic entry

Other names
Bacterial enzymeEnzyme of bacteriaMicrobial enzyme
02

Mechanism of action

Enzyme inhibition (e.g., β-lactam antibiotics inhibit cell wall–synthesizing transpeptidases and penicillin-binding proteins; β-lactamase inhibitors bind and block resistance enzymes)

03

Biological functions

Metabolism (catabolic and anabolic reactions)Cell wall synthesisProtein synthesisDNA/RNA replicationAntibiotic resistancePathogenicity/infectionSignal transduction (rare in prokaryotes, but some enzymes involved)
04

Disease associations

Infection (bacterial pathogens)Antibiotic resistanceOther (depends on enzyme; e.g., toxin production, virulence)
05

Safety considerations

Bystander effects: broad-spectrum enzyme inhibitors may disrupt commensal microbiotaRapid resistance: enzymes mutate or are horizontally transferred, conferring drug resistance (e.g., β-lactamase evolution)
06

Interacting drugs

β-lactam antibiotics (e.g., penicillins, cephalosporins; target transpeptidases and β-lactamases)

3 more in the full profile.

07

Biomarkers

Presence of specific resistance enzymes (e.g., β-lactamases for resistance phenotype prediction)Expression/activity of virulence-associated enzymes (e.g., DNases, proteases)

Beyond the preview

Go deeper on Bacterial cell enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call